The optimal biologic treatment target for hidradenitis suppurativa remains undiscovered

Alexander Egeberg; Jacob P Thyssen

doi:10.1016/S0140-6736(23)00059-4

The optimal biologic treatment target for hidradenitis suppurativa remains undiscovered

Department of Dermatology

1 Citation (Scopus)

Original language	English
Journal	Lancet
Volume	401
Issue number	10378
Pages (from-to)	708-710
Number of pages	3
ISSN	0140-6736
DOIs	https://doi.org/10.1016/S0140-6736(23)00059-4
Publication status	Published - 4 Mar 2023

Keywords

Humans
Hidradenitis Suppurativa
Biological Products

Access to Document

10.1016/S0140-6736(23)00059-4

Cite this

@article{d4e03b62f46847a8964619ef2f263a45,

title = "The optimal biologic treatment target for hidradenitis suppurativa remains undiscovered",

keywords = "Humans, Hidradenitis Suppurativa, Biological Products",

author = "Alexander Egeberg and Thyssen, \{Jacob P\}",

year = "2023",

month = mar,

day = "4",

doi = "10.1016/S0140-6736(23)00059-4",

language = "English",

volume = "401",

pages = "708--710",

journal = "Lancet",

issn = "0140-6736",

publisher = "Elsevier BV",

number = "10378",

}

TY - JOUR

T1 - The optimal biologic treatment target for hidradenitis suppurativa remains undiscovered

AU - Egeberg, Alexander

AU - Thyssen, Jacob P

PY - 2023/3/4

Y1 - 2023/3/4

KW - Humans

KW - Hidradenitis Suppurativa

KW - Biological Products

UR - https://www.scopus.com/pages/publications/85149723386

U2 - 10.1016/S0140-6736(23)00059-4

DO - 10.1016/S0140-6736(23)00059-4

M3 - Comment/debate

C2 - 36746172

SN - 0140-6736

VL - 401

SP - 708

EP - 710

JO - Lancet

JF - Lancet

IS - 10378

ER -

The optimal biologic treatment target for hidradenitis suppurativa remains undiscovered

Keywords

Access to Document

Other files and links

Cite this